Genome-scale CRISPR‒Cas9 screen identifies novel host factors as potential therapeutic targets for SARS-CoV-2 infectionMadoka Sakai(Kyoto University), Akiko Makino(Kyoto University)bioRxiv (Cold Spring Harbor Laboratory)March 7, 202310.1101/2023.03.06.531431Cited by 2SaveCiteExport RISWatch citationsRelated PapersGenome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection|iScience|2024|9